- Report
- August 2024
- 142 Pages
Asia Pacific
From €1426EUR$1,500USD£1,198GBP
- Report
- May 2022
- 93 Pages
Global
From €3660EUR$3,850USD£3,075GBP
- Report
- December 2023
- 111 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- April 2023
- 275 Pages
Global
From €3793EUR$3,990USD£3,187GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- January 2022
- 200 Pages
Global
From €7130EUR$7,500USD£5,990GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- May 2023
- 160 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- January 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- April 2023
- 129 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- August 2022
United States
From €1844EUR$1,940USD£1,549GBP
- Report
- August 2022
Global
From €751EUR$790USD£631GBP
- Report
- October 2024
- 90 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- June 2023
- 99 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- May 2022
- 91 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- April 2024
- 280 Pages
Global
From €3394EUR$3,570USD£2,851GBP

The Artery Disease Drug market is a subset of the Cardiovascular Drugs market, which focuses on the treatment of diseases related to the arteries. These drugs are used to reduce the risk of heart attack, stroke, and other cardiovascular diseases. They work by reducing the amount of cholesterol and other fatty substances in the blood, as well as by preventing the formation of blood clots. Common drugs used to treat artery disease include statins, antiplatelet drugs, and anticoagulants. These drugs are often prescribed in combination with lifestyle changes, such as diet and exercise, to reduce the risk of cardiovascular disease.
Some of the major companies in the Artery Disease Drug market include Pfizer, Merck, Sanofi, AstraZeneca, and Novartis. Show Less Read more